Jerusalem Pharmaceuticals Market Cap

Jerusalem Pharmaceuticals has a market cap or net worth of 47.20 million as of May 13, 2025. Its market cap has increased by 35.53% in one year.

Market Cap

47.20M

Enterprise Value

40.60M

Revenue

28.25M

Ranking

n/a

PE Ratio

13.22

Stock Price

3.70

Market Cap Chart

Since December 15, 2008, Jerusalem Pharmaceuticals's market cap has increased from 14.89M to 47.20M, an increase of 217.03%. That is a compound annual growth rate of 7.28%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	47.20M	-3.56%
Dec 24, 2024	48.95M	0.78%
Dec 31, 2023	48.57M	15.89%
Dec 29, 2022	41.91M	16.10%
Dec 23, 2021	36.10M	2.12%
Dec 31, 2020	35.35M	-1.04%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Palestine Telecommunications Company P.L.C	519.92M
Bank of Palestine	275.66M
Arab Palestinian Investment Company	198.52M
Palestine Development & Investment Co.	170.83M
Wataniya Palestine Mobile Telecommunication - Public Shareholding Company	143.34M
Arkaan Real Estate P.L.C	123.22M
The National Bank	105.05M
Birzeit Pharmaceuticals Company	98.87M

Market Cap Rankings